# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Ampio Pharmaceuticals (AMEX:AMPE) reported quarterly losses of $(2.48) per share. This is a 31.11 percent increase over losses ...
The Company today notified the NYSE American of its intention to voluntarily delist its shares of common stock from the NYSE Am...
- SEC Filing On February 26, 2024, Ampio Pharmaceuticals, Inc. (the "Company") provided a notice to H.C. Wainwright &am...
The Company's management and the Board are currently assessing both internal and external options.